Moral courage in the workplace: moving to and from the desire and decision to act

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72135/1/j.1467-8608.2007.00484.x.pd

Virtual team performance in a highly competitive environment

In this article, we empirically validate a version of the input-mediator-output-input (IMOI) model (Ilgen, Hollenbeck, Johnson, & Jundt, 2005), adapting it to investigate virtual team performance in a highly competitive environment. Our hypotheses are tested using structural equation modeling across time periods with data obtained from 606 professional online gaming teams belonging to the European Electronic Sports League. The findings validate the hypothesized IMOI model, and demonstrate the effects of anticipated emotions on shared motivation of team members. The results contribute to theory and have significant implications for the management of geographically distributed work groups

Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer : final results of a phase II study

Purpose: We performed a phase II study to assess feasibility, pain relief, and toxicity of a tetracaine-based oral gel in the treatment of radiotherapy (RT)-induced mucositis. Methods and Materials: Fifty patients treated with RT for head-and-neck cancer with clinical evidence of acute oral mucositis of grade 2:2 were scheduled to receive the tetracaine gel. A questionnaire evaluating the effect of the gel was given to all subjects. Results: In 38 patients (79.2%), a reduction in oral cavity pain was reported. Thirty-four patients (82.9%) reported no side effect. Seventy-one percent of patients had no difficulties in gel application. Unpleasant taste of the gel and interference with food taste were noticed in 5 (12%) and 16 patients (39%), respectively. Planned RT course was interrupted less frequently in patients who reported benefit from gel application than in patients who did not (p = 0.014). None of the patients who experienced pain relief needed a nasogastric tube, opposite to the patients who did not report any benefit from gel application (p = 0.001). Conclusion: Tetracaine oral gel administration seemed feasible and safe while reducing RT-induced mucositis-related oral pain in a sizeable proportion of treated head-and-neck cancer patients. A trial designed to compare efficacy of this gel vs. standard treatment is warranted